©2026 Incunabulum LLC. All rights reserved. mg Magazine is a registered trademark of Incunabulum LLC. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with prior written permission.
Tag: Drug Enforcement Administration
Consumer Brands Association to Advocate for Consumer Safety of CBD Products
ARLINGTON, Va. – The Consumer Brands Association (CBA), an advocacy group dedicated to consumer protection, has created an advisory board to...
Congress Considers Cannabis Reform, Research Restrictions, and More
WASHINGTON, D.C. – The Health subcommittee for the U.S. House Committee on Energy and Commerce on Wednesday held a three-plus hours-long hearing on the...
Congress to Consider Multiple Cannabis Reform Bills in Subcommittee Hearing
WASHINGTON, D.C. – 2020 could be shaping up to be a major turning point for federal cannabis law.Multiple cannabis reform bills will be debated...
USDA Extends Deadline for Hemp Program Comments; States Seek Policy Change
WASHINGTON, D.C. – The United States Department of Agriculture (USDA) has extended the comment period for its interim final rules regarding the U.S. Domestic...
Dispatch: International Association of Cannabinoid Medicines Conference
BERLIN – Accepting the International Association of Cannabinoid Medicines’ (IACM) award for major contributions to cannabinoid basic research at a gala dinner during the...
Bernie Sanders’ Plan Would Legalize Cannabis in First 100 Days of Presidency
Federal cannabis legalization could become a reality after the 2020 presidential election, especially if Senator Bernie Sanders (D-Vt.) takes the White House.
The longtime cannabis...
NCIA Letter to Congress Calls for Federal Action in Vaping Epidemic
WASHINGTON, D.C. – The National Cannabis Industry Association (NCIA) today delivered a letter to the U.S. House of Representatives urging Congress to take federal...
DEA Again Announces Intention to Process Cannabis Research Applications
WASHINGTON, D.C. – Although cannabis consumption has been rapidly increasing in recent years, formal research into the benefits and risks of the plant are lagging...
DEA Classifies CBD-based Epidiolex as Schedule V Controlled Substance
WASHINGTON, D.C. – On Friday, the United States Drug Enforcement Administration is expected to issue a final order placing Epidiolex on Schedule V of the Controlled...
Rite Aid Says It’s Ready to Sell Cannabis-based Epidiolex
ATLANTA–News outlet CNN reported today that a spokesperson for Rite Aid Drug Stores said the national pharmacy store chain is ready to sell cannabis-based...